A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potential

Citations of this article
Mendeley users who have this article in their library.


We have developed a yeast-based model recapitulating neurotoxicity of α-synuclein fibrilization. This model recognized metal ions, known risk factors of α-synucleinopathy, as stimulators of α-synuclein aggregation and cytotoxicity. Elimination of Yca1 caspase activity augmented both cytotoxicity and inclusion body formation, suggesting the involvement of apoptotic pathway components in toxic α-synuclein amyloidogenesis. Deletion of hydrophobic amino acids at positions 66-74 in α-synuclein reduced its cytotoxicity but, remarkably, did not lower the levels of insoluble α-synuclein, indicating that noxious α-synuclein species are different from insoluble aggregates. A compound screen aimed at finding molecules with therapeutic potential identified flavonoids with strong activity to restrain α-synuclein toxicity. Subsequent structure-activity analysis elucidated that these acted by virtue of anti-oxidant and metal-chelating activities. In conclusion, this yeast-cell model as presented allows not only fundamental studies related to mechanisms of α-synuclein-instigated cellular degeneration, but is also a valid high-throughput identification tool for novel neuroprotective agents. © 2005 Elsevier B.V. All rights reserved.




Griffioen, G., Duhamel, H., Van Damme, N., Pellens, K., Zabrocki, P., Pannecouque, C., … Wera, S. (2006). A yeast-based model of α-synucleinopathy identifies compounds with therapeutic potential. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1762(3), 312–318. https://doi.org/10.1016/j.bbadis.2005.11.009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free